Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BioNexus Gene Lab (BGLC) Other Operating Expenses (2024 - 2025)

BioNexus Gene Lab's Other Operating Expenses history spans 2 years, with the latest figure at $2.4 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 124.18% year-over-year to $2.4 million; the TTM value through Sep 2025 reached -$7.1 million, down 801.63%, while the annual FY2024 figure was -$8.9 million, 4.48% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $2.4 million at BioNexus Gene Lab, up from $142639.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2.4 million in Q3 2025 and bottomed at -$7.8 million in Q4 2024.